Substrate
science

Study Describes DNA Changes That Prevent Self-Reactive Antibodies

Researchers identified sequence alterations in antibody genes that maintain diversity while blocking formation of self-targeting antibodies. The findings appear in a paper published in Nature.

NA
1 source·May 19, 1:42 PM(10 days ago)·1m read
Study Describes DNA Changes That Prevent Self-Reactive Antibodiesneurosciencenews.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

A new study published in Nature examines how the immune system generates millions of distinct antibodies daily while avoiding production of antibodies that attack the body's own tissues. Li et al. report that specific changes in antibody-encoding DNA sequences support generation of a wide antibody repertoire and simultaneously prevent formation of genes that encode self-reacting antibodies.

The body produces large numbers of antibodies to fight infections. Earlier research has shown that antibody genes undergo rearrangement and editing processes during immune-cell development.

The study describes a process called linear RAG scanning that mediates editing of Igκ variable region repertoires. This scanning mechanism limits the creation of self-reactive antibody genes. " — Li et al.

Key Facts

Antibody DNA changes
prevent self-reactive antibody formation
Linear RAG scanning
edits Igκ variable region repertoires
Circular DNA levels
linked to leukemia relapse risk

Potential Impact

  1. 01

    Further research may examine how these DNA changes relate to autoimmune conditions.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count122 words
PublishedMay 19, 2026, 1:42 PM
Bias signals removed2 across 1 outlet
Signal Breakdown
Editorializing 1Amplifying 1

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science4 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science2 hrs agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science6 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source